KATHERINE HILL: Open Payments
NPI 1700658952 · RUSHVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 51 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $528 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $195 |
| ABBVIE INC. | 10 | $183 |
| Otsuka America Pharmaceutical, Inc. | 11 | $161 |
| Alkermes, Inc. | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Lundbeck LLC | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, REXULTI, ARISTADA, FANAPT, ABILIFY ASIMTUFII, COBENFY, SPRAVATO.
Industry payments across IN — which companies pay providers there.
